KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Non-Current Debt: 2009-2024

Historic Non-Current Debt for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $2.2 billion.

  • Charles River Laboratories International's Non-Current Debt fell 6.07% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 6.07%. This contributed to the annual value of $2.2 billion for FY2024, which is 15.37% down from last year.
  • As of FY2024, Charles River Laboratories International's Non-Current Debt stood at $2.2 billion, which was down 15.37% from $2.6 billion recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Non-Current Debt registered a high of $2.7 billion during FY2022, and its lowest value of $1.9 billion during FY2020.
  • Moreover, its 3-year median value for Non-Current Debt was $2.6 billion (2023), whereas its average is $2.5 billion.
  • In the last 5 years, Charles River Laboratories International's Non-Current Debt spiked by 38.04% in 2021 and then dropped by 15.37% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Debt (Yearly) stood at $1.9 billion in 2020, then surged by 38.04% to $2.7 billion in 2021, then climbed by 1.65% to $2.7 billion in 2022, then declined by 2.23% to $2.6 billion in 2023, then declined by 15.37% to $2.2 billion in 2024.